Pfizer: 2020 Breast Cancer Competitive Research Grant Program for Africa, the Middle East, Asia and Latin America Regions

Aim: proposals focusing in the areas including: o Real-word studies on breast cancer epidemiology, patient population, and treatment landscape in a particular country or region o Studies to understand clinical outcomes in patients with HR+, HER2- metastatic breast cancer of various social economic status o Clinical studies incorporating correlative/biomarker component using paired biopsy samples o Evaluation of optimal clinical and/or nursing management approaches during palbociclib treatment. Funding not specified, 15 grants anticipated.

https://pfe-pfizercom-prod.s3.amazonaws.com/Pfizer_BCCGP_AfME_Asia_LatAm_RFP_FINAL_11262019_second_update.pdf